These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27906610)

  • 21. Increased Incidence of Central Venous Catheter-Related Infection in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy.
    Waters PS; Smith AW; Fitzgerald E; Khan F; Moran BJ; Shields CJ; Lynch BL; O'Loughlin C; Lynch M; Mulsow J
    Surg Infect (Larchmt); 2019 Sep; 20(6):465-471. PubMed ID: 31013189
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Kuijpers AM; Mehta AM; Aalbers AG; van Driel WJ; Boot H; Verwaal VJ
    Eur J Surg Oncol; 2014 Aug; 40(8):937-42. PubMed ID: 24630923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment-Related Mortality After Cytoreductive Surgery and HIPEC in Patients with Colorectal Peritoneal Carcinomatosis is Underestimated by Conventional Parameters.
    Simkens GA; van Oudheusden TR; Braam HJ; Luyer MD; Wiezer MJ; van Ramshorst B; Nienhuijs SW; de Hingh IH
    Ann Surg Oncol; 2016 Jan; 23(1):99-105. PubMed ID: 26148758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indications for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in elderly patients with peritoneal malignancy.
    Kitai T; Yamanaka K; Miyauchi Y; Kawashima M
    Int J Clin Oncol; 2017 Jun; 22(3):519-525. PubMed ID: 28054141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extensive surgical history prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is associated with poor survival outcomes in patients with peritoneal mucinous carcinomatosis of appendiceal origin.
    Milovanov V; Sardi A; Aydin N; Nieroda C; Sittig M; Nunez M; Gushchin V
    Eur J Surg Oncol; 2015 Jul; 41(7):881-5. PubMed ID: 25899982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with thromboembolic events following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Rottenstreich A; Kalish Y; Kleinstern G; Yaacov AB; Dux J; Nissan A
    J Surg Oncol; 2017 Dec; 116(7):914-920. PubMed ID: 28650573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: the experience of a tertiary Asian center.
    Teo MC; Ching Tan GH; Lim C; Chia CS; Tham CK; Soo KC
    Asian J Surg; 2015 Apr; 38(2):65-73. PubMed ID: 25059814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies.
    Passot G; Bakrin N; Isaac S; Decullier E; Gilly FN; Glehen O; Cotte E
    Eur J Surg Oncol; 2014 Aug; 40(8):957-62. PubMed ID: 24209429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Digestive fistulas after cytoreductive surgery & HIPEC in peritoneal carcinomatosis.
    Halkia E; Efstathiou E; Rogdakis A; Christakis C; Spiliotis J
    J BUON; 2015 May; 20 Suppl 1():S60-3. PubMed ID: 26051334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does having a gastrectomy delay time to feeding and prolong hospital stay in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?
    Shannon NB; Tan GHC; Chia CS; Soo KC; Teo MC
    Int J Hyperthermia; 2018 Aug; 34(5):518-523. PubMed ID: 28689443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Appendiceal goblet cell carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Randle RW; Griffith KF; Fino NF; Swett KR; Stewart JH; Shen P; Levine EA; Votanopoulos KI
    J Surg Res; 2015 Jun; 196(2):229-34. PubMed ID: 25881787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperthermic intraperitoneal chemotherapy plus simultaneous versus staged cytoreductive surgery for gastric cancer with occult peritoneal metastasis.
    Wu X; Li Z; Li Z; Jia Y; Shan F; Ji X; Bu Z; Zhang L; Wu A; Ji J
    J Surg Oncol; 2015 Jun; 111(7):840-7. PubMed ID: 25864884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re-admissions for delayed complications after cytoreductive surgery and HIPEC.
    Spiliotis J; Argiriou EO; Vafias E; Manou V; Vaos N; Datsis A; Efstathiou E
    Acta Chir Belg; 2016 Apr; 116(2):96-100. PubMed ID: 27385296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ninety-day post-operative morbidity and mortality using the National Cancer Institute's common terminology criteria for adverse events better describe post-operative outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Alyami M; Kim BJ; Villeneuve L; Vaudoyer D; Képénékian V; Bakrin N; Gilly FN; Cotte E; Glehen O; Passot G
    Int J Hyperthermia; 2018 Aug; 34(5):532-537. PubMed ID: 28838265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center.
    Wu HT; Peng KW; Ji ZH; Sun JH; Zhang Q; Yang XJ; Huang CQ; Li Y
    Eur J Surg Oncol; 2016 Jul; 42(7):1024-34. PubMed ID: 27179924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of diabetes on morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
    Randle RW; Ahmed S; Levine EA; Fino NF; Swett KR; Stewart JH; Shen P; Votanopoulos KI
    J Surg Oncol; 2015 May; 111(6):740-5. PubMed ID: 25556634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center.
    Muñoz-Casares FC; Medina-Fernández FJ; Arjona-Sánchez Á; Casado-Adam Á; Sánchez-Hidalgo JM; Rubio MJ; Ortega-Salas R; Muñoz-Villanueva MC; Rufián-Peña S; Briceño FJ
    Eur J Surg Oncol; 2016 Feb; 42(2):224-33. PubMed ID: 26673283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytoreduction and hyperthermic intraperitoneal chemotherapy: The learning curve reassessed.
    Kuijpers AM; Hauptmann M; Aalbers AG; Nienhuijs SW; de Hingh IH; Wiezer MJ; van Ramshorst B; van Ginkel RJ; Havenga K; Verwaal VJ
    Eur J Surg Oncol; 2016 Feb; 42(2):244-50. PubMed ID: 26375923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of gastric resections during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.
    Piso P; Slowik P; Popp F; Dahlke MH; Glockzin G; Schlitt HJ
    Ann Surg Oncol; 2009 Aug; 16(8):2188-94. PubMed ID: 19408049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytoreductive surgery and HIPEC for peritoneal carcinomatosis. A review on morbidity and mortality.
    Halkia E; Kopanakis N; Nikolaou G; Spiliotis J
    J BUON; 2015 May; 20 Suppl 1():S80-7. PubMed ID: 26051337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.